CannTrust’s Q1 revenue doubles on medical marijuana sales; net income up

Just Released! Get realistic market forecasts, state-by-state insights and benchmarks with the new 2024 MJBiz Factbook member program, now with quarterly updates. Make informed decisions.

Ontario, Canada-based CannTrust Holdings reported that first-quarter revenue more than doubled from a year earlier, mostly on the back of rising medical marijuana sales, while the company’s net income inched higher. Adult-use sales, however, struggled.

First-quarter revenue jumped 115% from a year earlier to 16.9 million Canadian dollars ($12.6 million), thanks to strength in the company’s MMJ business. CannTrust said its active patient count reached 68,000 as of March 31, a 70% increase over the first quarter of 2018.

The company’s net income increased to CA$12.8 million in the first quarter from CA$11.4 million a year earlier.

However, CannTrust reported lower net revenue from wholesale cannabis in the first quarter – the company’s first full financial quarter of recreational sales – as Canada’s federal license holders continue to struggle to turn a profit selling legal recreational marijuana.

Wholesale net revenue – primarily reflecting sales to provinces for the adult-use market – fell in the January-March period to CA$5.5 million from CA$6.5 million in the fourth quarter of 2018.

Canada legalized recreational marijuana on Oct. 17, 2018.

CannTrust shares trade as CTST on the New York Stock Exchange and as TRST on the Toronto Stock Exchange.